STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

ENANTA PHARMACEUTICALS INC

Filed

November 28, 2022

Period of Report

November 23, 2022

Accession Number

0001062993-22-022846